日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An (211)At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma

一种用于转移性黑色素瘤靶向α疗法的(211)At标记的α-促黑素细胞激素肽类似物

Suzuki, Hiroyuki; Yamashita, Saki; Tanaka, Shoko; Kannaka, Kento; Sasaki, Ichiro; Ohshima, Yasuhiro; Watanabe, Shigeki; Ooe, Kazuhiro; Watabe, Tadashi; Ishioka, Noriko S; Tanaka, Hiroshi; Uehara, Tomoya

Scale-up production of [(211)At]PSMA-5 using automated synthesizer for Investigator-Initiated clinical trial

利用自动化合成仪扩大[(211)At]PSMA-5的生产规模,用于研究者发起的临床试验

Naka, Sadahiro; Watabe, Tadashi; Shirakami, Yoshifumi; Ooe, Kazuhiro; Kurimoto, Kenta; Sakai, Toshihiro; Toyoshima, Atsushi; Murakami, Masashi; Kon, Yukiyoshi; Haba, Hiromitsu; Cardinale, Jens; Giesel, Frederik L; Isohashi, Kayako; Tomiyama, Noriyuki

First-in-Human Study of [(211)At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial)

首次人体研究:[(211)At]NaAt 作为靶向 α 疗法治疗放射性碘难治性甲状腺癌患者(Alpha-T1 试验)

Watabe, Tadashi; Mukai, Kosuke; Naka, Sadahiro; Sasaki, Hidetaka; Kamiya, Takashi; Hayakawa, Tomoaki; Fukuhara, Atsunori; Takano, Toru; Shirakami, Yoshifumi; Ooe, Kazuhiro; Shigeno, Satoshi; Okamura, Satomi; Masumura, Kazuho; Hida, Eisuke; Haba, Hiromitsu; Toyoshima, Atsushi; Isohashi, Kayako; Shimomura, Iichiro; Tomiyama, Noriyuki

Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides

α发射核素中靶向PSMA的核医学疗法的比较

Kaneda-Nakashima, Kazuko; Shirakami, Yoshifumi; Kadonaga, Yuichiro; Watabe, Tadashi; Ooe, Kazuhiro; Yin, Xiaojie; Haba, Hiromitsu; Shirasaki, Kenji; Kikunaga, Hidetoshi; Tsukada, Kazuaki; Toyoshima, Atsushi; Cardinale, Jens; Giesel, Frederik L; Fukase, Koichi

Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211

利用砹-211开发LAT1选择性核医学疗法

Kaneda-Nakashima, Kazuko; Shirakami, Yoshifumi; Hisada, Kentaro; Feng, Sifan; Kadonaga, Yuichiro; Ooe, Kazuhiro; Watabe, Tadashi; Manabe, Yoshiyuki; Shimoyama, Atsushi; Murakami, Masashi; Toyoshima, Atsushi; Haba, Hiromitsu; Kanai, Yoshikatsu; Fukase, Koichi

Production of [(211)At]NaAt solution under GMP compliance for investigator-initiated clinical trial

在符合GMP规范的条件下生产[(211)At]NaAt溶液,用于研究者发起的临床试验

Naka, Sadahiro; Ooe, Kazuhiro; Shirakami, Yoshifumi; Kurimoto, Kenta; Sakai, Toshihiro; Takahashi, Kazuhiro; Toyoshima, Atsushi; Wang, Yang; Haba, Hiromitsu; Kato, Hiroki; Tomiyama, Noriyuki; Watabe, Tadashi

Targeted α-therapy using astatine ((211)At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound

利用砹((211)At)标记的PSMA1、5和6进行靶向α疗法:一种新型化合物的临床前评估

Watabe, Tadashi; Kaneda-Nakashima, Kazuko; Shirakami, Yoshifumi; Kadonaga, Yuichiro; Ooe, Kazuhiro; Wang, Yang; Haba, Hiromitsu; Toyoshima, Atsushi; Cardinale, Jens; Giesel, Frederik L; Tomiyama, Noriyuki; Fukase, Koichi

Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy

探索一种用于高效靶向α疗法的核选择性放射性同位素输送系统

Iizuka, Yuki; Manabe, Yoshiyuki; Ooe, Kazuhiro; Toyoshima, Atsushi; Yin, Xiaojie; Haba, Hiromitsu; Kabayama, Kazuya; Fukase, Koichi

Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice

小鼠体内砹-211内剂量测定成像系统的研制与应用

Yagishita, Atsushi; Katsuragawa, Miho; Takeda, Shin'ichiro; Shirakami, Yoshifumi; Ooe, Kazuhiro; Toyoshima, Atsushi; Takahashi, Tadayuki; Watabe, Tadashi

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection

用于静脉注射靶向α粒子治疗的砹-211标记金纳米粒子

Huang, Xuhao; Kaneda-Nakashima, Kazuko; Kadonaga, Yuichiro; Kabayama, Kazuya; Shimoyama, Atsushi; Ooe, Kazuhiro; Kato, Hiroki; Toyoshima, Atsushi; Shinohara, Atsushi; Haba, Hiromitsu; Wang, Yang; Fukase, Koichi